Related Experiment Videos
[Changes in chemotherapy for pancreatic adenocarcinoma]
Gastroenterologie Clinique Et Biologique
|August 24, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD study.
medRxiv : the preprint server for health sciences·2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
The New England journal of medicine·2026
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010
Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.
Human vaccines & immunotherapeutics·2026
CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively.
Hematology (Amsterdam, Netherlands)·2026
Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.
Asia-Pacific journal of clinical oncology·2026